The Initial Hormone Receptor/her2 Subtype is the Main Determinator of Subtype Discordance in Advanced Breast Cancer: a Study of the SONABRE Registry.
Meegdes Marissa,Ibragimova Khava I. E.,Lobbezoo Dorien J. A.,Vriens Ingeborg J. H.,Kooreman Loes F. S.,Erdkamp Frans L. G.,Dercksen M. Wouter,Vriens Birgit E. P. J.,Aaldering Kirsten N. A.,Pepels Manon J. A. E.,van de Winkel Linda M. H.,Tol Jolien,Heijns Joan B.,van de Wouw Agnes J.,Peters Natascha A. J. B., Hochstenbach-Waelen Ananda,Smidt Marjolein L.,Geurts Sandra M. E.,Tjan-Heijnen Vivianne C. G. Breast Cancer Research and Treatment(2022)
关键词
Breast cancer,Metastatic disease,Hormone receptor,HER2 receptor,Subtype,Biopsy
AI 理解论文
溯源树
样例
